InvestorsHub Logo
Followers 13
Posts 697
Boards Moderated 0
Alias Born 01/12/2013

Re: blackhawks post# 80971

Saturday, 08/17/2013 3:28:05 PM

Saturday, August 17, 2013 3:28:05 PM

Post# of 130503
I feel MANF is still way in its infancy; however, the potential is enormous(as Jason N. has indicated in his Zacks analyst report). Also, I feel Dr. Rubinfeld will lead the Orphan indications down the right path.

S/T ...its all about the funding capabilities. Can Gerald attract L/T quality institutions who are willing to finance and progress the Science.

I think Sept. is going to be a HUGE corner and eventually a critical turning point (from a timing standpoint)...as so many possible catalysts are looming (LymPro validation, possible Financing, additional MANF Orphan indications, MANF delivery partnership and jut maybe some progress with NuroPro is looming as well (at leas the remainder of 2013 and 2014 should be very exciting).